By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Identifying and developing innovative therapies to address significant unmet needs for2M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States7.83M100.00%